Tag Archives | Simon Li

SciClone Pharmaceuticals

SciClone Pharmaceuticals: Proxy Score 78

SciClone Pharmaceuticals, Inc. (NASD:SCLN) is one of the stocks in my portfolio. Their product portfolio of therapies includes oncology, infectious diseases and cardiovascular disorders.discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. Their annual meeting is coming up on 6/11/2015. ProxyDemocracy.org had the vote of one […]

Continue Reading ·

Powered by WordPress. Designed by WooThemes